- Home
- BITF vs ANIP Comparison
BITF vs ANIP Comparison
Compare BITF & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BITF
- ANIP
- Stock Information
- Founded
- BITF 2017
- ANIP 2001
- Country
- BITF Canada
- ANIP United States
- Employees
- BITF N/A
- ANIP N/A
- Industry
- BITF Finance: Consumer Services
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- BITF Finance
- ANIP Health Care
- Exchange
- BITF Nasdaq
- ANIP Nasdaq
- Market Cap
- BITF 1.7B
- ANIP 2.0B
- IPO Year
- BITF N/A
- ANIP N/A
- Fundamental
- Price
- BITF $4.54
- ANIP $94.22
- Analyst Decision
- BITF Strong Buy
- ANIP Strong Buy
- Analyst Count
- BITF 3
- ANIP 7
- Target Price
- BITF $3.83
- ANIP $99.14
- AVG Volume (30 Days)
- BITF 124.4M
- ANIP 246.7K
- Earning Date
- BITF 11-12-2025
- ANIP 11-07-2025
- Dividend Yield
- BITF N/A
- ANIP N/A
- EPS Growth
- BITF N/A
- ANIP N/A
- EPS
- BITF N/A
- ANIP N/A
- Revenue
- BITF $245,664,000.00
- ANIP $747,399,000.00
- Revenue This Year
- BITF $62.42
- ANIP $39.99
- Revenue Next Year
- BITF $11.07
- ANIP $9.57
- P/E Ratio
- BITF N/A
- ANIP N/A
- Revenue Growth
- BITF 42.25
- ANIP 38.68
- 52 Week Low
- BITF $0.67
- ANIP $52.50
- 52 Week High
- BITF $6.60
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- BITF 57.59
- ANIP 57.96
- Support Level
- BITF $3.70
- ANIP $93.00
- Resistance Level
- BITF $5.41
- ANIP $95.94
- Average True Range (ATR)
- BITF 0.68
- ANIP 2.45
- MACD
- BITF -0.13
- ANIP 0.38
- Stochastic Oscillator
- BITF 38.64
- ANIP 74.87
About BITF Bitfarms Ltd.
Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.